vs
MERCURY SYSTEMS INC（MRCY）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
MERCURY SYSTEMS INC的季度营收约是REPLIGEN CORP的1.2倍（$232.9M vs $197.9M），REPLIGEN CORP净利率更高（6.7% vs -6.5%，领先13.2%），REPLIGEN CORP同比增速更快（13.6% vs 4.4%），MERCURY SYSTEMS INC自由现金流更多（$45.7M vs $17.6M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 5.7%）
Mercury Systems是一家服务于航空航天与国防领域的科技企业，专注于设计、研发及生产开放式架构计算机软硬件产品，覆盖安全嵌入式处理模块与子系统、航电任务计算机及显示器、加固型安全服务器、可信微电子组件与子系统等多类产品。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
MRCY vs RGEN — 直观对比
营收规模更大
MRCY
是对方的1.2倍
$197.9M
营收增速更快
RGEN
高出9.3%
4.4%
净利率更高
RGEN
高出13.2%
-6.5%
自由现金流更多
MRCY
多$28.2M
$17.6M
两年增速更快
RGEN
近两年复合增速
5.7%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $232.9M | $197.9M |
| 净利润 | $-15.1M | $13.3M |
| 毛利率 | 26.0% | 52.5% |
| 营业利润率 | -4.6% | 9.0% |
| 净利率 | -6.5% | 6.7% |
| 营收同比 | 4.4% | 13.6% |
| 净利润同比 | 14.1% | 143.9% |
| 每股收益（稀释后） | $-0.26 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MRCYRGEN
| Q4 25 | $232.9M | $197.9M | ||
| Q3 25 | $225.2M | $188.8M | ||
| Q2 25 | $273.1M | $182.4M | ||
| Q1 25 | $211.4M | $169.2M | ||
| Q4 24 | $223.1M | $174.1M | ||
| Q3 24 | $204.4M | $154.9M | ||
| Q2 24 | $248.6M | $154.1M | ||
| Q1 24 | $208.3M | $151.3M |
净利润MRCYRGEN
| Q4 25 | $-15.1M | $13.3M | ||
| Q3 25 | $-12.5M | $14.9M | ||
| Q2 25 | $16.4M | $14.9M | ||
| Q1 25 | $-19.2M | $5.8M | ||
| Q4 24 | $-17.6M | $-30.3M | ||
| Q3 24 | $-17.5M | $-654.0K | ||
| Q2 24 | $-10.8M | $3.3M | ||
| Q1 24 | $-44.6M | $2.1M |
毛利率MRCYRGEN
| Q4 25 | 26.0% | 52.5% | ||
| Q3 25 | 27.9% | 53.2% | ||
| Q2 25 | 31.0% | 50.0% | ||
| Q1 25 | 27.0% | 53.6% | ||
| Q4 24 | 27.3% | 26.1% | ||
| Q3 24 | 25.3% | 50.0% | ||
| Q2 24 | 29.5% | 49.8% | ||
| Q1 24 | 19.5% | 49.5% |
营业利润率MRCYRGEN
| Q4 25 | -4.6% | 9.0% | ||
| Q3 25 | -3.8% | 8.9% | ||
| Q2 25 | 8.6% | 7.6% | ||
| Q1 25 | -8.2% | 3.9% | ||
| Q4 24 | -5.6% | -17.7% | ||
| Q3 24 | -6.6% | -5.1% | ||
| Q2 24 | -3.2% | 1.0% | ||
| Q1 24 | -21.9% | 1.3% |
净利率MRCYRGEN
| Q4 25 | -6.5% | 6.7% | ||
| Q3 25 | -5.6% | 7.9% | ||
| Q2 25 | 6.0% | 8.2% | ||
| Q1 25 | -9.1% | 3.4% | ||
| Q4 24 | -7.9% | -17.4% | ||
| Q3 24 | -8.6% | -0.4% | ||
| Q2 24 | -4.3% | 2.2% | ||
| Q1 24 | -21.4% | 1.4% |
每股收益（稀释后）MRCYRGEN
| Q4 25 | $-0.26 | $0.24 | ||
| Q3 25 | $-0.21 | $0.26 | ||
| Q2 25 | $0.28 | $0.26 | ||
| Q1 25 | $-0.33 | $0.10 | ||
| Q4 24 | $-0.30 | $-0.55 | ||
| Q3 24 | $-0.30 | $-0.01 | ||
| Q2 24 | $-0.18 | $0.06 | ||
| Q1 24 | $-0.77 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $335.0M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $1.5B | $2.1B |
| 总资产 | $2.5B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资MRCYRGEN
| Q4 25 | $335.0M | $767.6M | ||
| Q3 25 | $304.7M | $748.7M | ||
| Q2 25 | $309.1M | $708.9M | ||
| Q1 25 | $269.8M | $697.2M | ||
| Q4 24 | $242.6M | $757.4M | ||
| Q3 24 | $158.1M | $784.0M | ||
| Q2 24 | $180.5M | $809.1M | ||
| Q1 24 | $142.6M | $780.6M |
总债务MRCYRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益MRCYRGEN
| Q4 25 | $1.5B | $2.1B | ||
| Q3 25 | $1.5B | $2.1B | ||
| Q2 25 | $1.5B | $2.1B | ||
| Q1 25 | $1.5B | $2.0B | ||
| Q4 24 | $1.5B | $2.0B | ||
| Q3 24 | $1.5B | $2.0B | ||
| Q2 24 | $1.5B | $2.0B | ||
| Q1 24 | $1.5B | $2.0B |
总资产MRCYRGEN
| Q4 25 | $2.5B | $2.9B | ||
| Q3 25 | $2.5B | $2.9B | ||
| Q2 25 | $2.4B | $2.9B | ||
| Q1 25 | $2.4B | $2.9B | ||
| Q4 24 | $2.4B | $2.8B | ||
| Q3 24 | $2.4B | $2.8B | ||
| Q2 24 | $2.4B | $2.9B | ||
| Q1 24 | $2.4B | $2.8B |
负债/权益比MRCYRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $51.6M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $45.7M | $17.6M |
| 自由现金流率自由现金流/营收 | 19.6% | 8.9% |
| 资本支出强度资本支出/营收 | 2.5% | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | $99.4M | $93.9M |
8季度趋势，按日历期对齐
经营现金流MRCYRGEN
| Q4 25 | $51.6M | $25.7M | ||
| Q3 25 | $2.2M | $48.1M | ||
| Q2 25 | $38.1M | $28.6M | ||
| Q1 25 | $30.0M | $15.0M | ||
| Q4 24 | $85.5M | $39.2M | ||
| Q3 24 | $-14.7M | $49.3M | ||
| Q2 24 | $71.8M | $42.2M | ||
| Q1 24 | $-17.8M | $44.7M |
自由现金流MRCYRGEN
| Q4 25 | $45.7M | $17.6M | ||
| Q3 25 | $-4.4M | $43.4M | ||
| Q2 25 | $34.0M | $21.5M | ||
| Q1 25 | $24.1M | $11.4M | ||
| Q4 24 | $81.9M | $33.6M | ||
| Q3 24 | $-20.9M | $42.3M | ||
| Q2 24 | $61.4M | $37.4M | ||
| Q1 24 | $-25.7M | $36.4M |
自由现金流率MRCYRGEN
| Q4 25 | 19.6% | 8.9% | ||
| Q3 25 | -1.9% | 23.0% | ||
| Q2 25 | 12.4% | 11.8% | ||
| Q1 25 | 11.4% | 6.8% | ||
| Q4 24 | 36.7% | 19.3% | ||
| Q3 24 | -10.2% | 27.3% | ||
| Q2 24 | 24.7% | 24.3% | ||
| Q1 24 | -12.4% | 24.0% |
资本支出强度MRCYRGEN
| Q4 25 | 2.5% | 4.1% | ||
| Q3 25 | 2.9% | 2.5% | ||
| Q2 25 | 1.5% | 3.9% | ||
| Q1 25 | 2.8% | 2.1% | ||
| Q4 24 | 1.6% | 3.2% | ||
| Q3 24 | 3.1% | 4.5% | ||
| Q2 24 | 4.2% | 3.1% | ||
| Q1 24 | 3.8% | 5.5% |
现金转化率MRCYRGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | — | 3.23× | ||
| Q2 25 | 2.33× | 1.92× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 12.70× | ||
| Q1 24 | — | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MRCY
| Airborne | $84.2M | 36% |
| Components | $48.7M | 21% |
| Other End Applications | $36.8M | 16% |
| Electronic Warfare | $27.5M | 12% |
| Other Sensor And Effector Applications | $23.9M | 10% |
| Space | $11.9M | 5% |
RGEN
暂无分部数据
